CHD5 and chronic myelogenous leukemia, BCR-ABL1 positive: Statistical analysis revealed that distributions of CHD5 mRNA and protein expression were significantly lower in ALL, AML and CML than in NMCs (Figure 1 CD; P≤0.001).